Related Experiment Video
Updated: Sep 30, 2025

06:38
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
Published on: December 8, 2023
1.2K
[Exploration of vaccine immunogenicity]
Jessica Denis1,2, Marie Mura1,3,2, Aurélie Trignol4
1Unité immunopathologie, Institut de recherche biomédicale des armées, 1 place du général-Valérie-André, 91220 Brétigny-sur-Orge, France.
Revue Francophone Des Laboratoires : RFL
|March 14, 2022
Summary
Vaccine development traditionally takes years, but COVID-19 highlighted delays. Early vaccine research focuses on the adaptive immune system
Area of Science:
- Immunology
- Vaccinology
Context:
- Traditional vaccine development is lengthy.
- Emerging infectious diseases like COVID-19 can cause significant delays.
- Current vaccine research heavily relies on understanding adaptive immunity.
Purpose:
- To outline the traditional timeline of vaccine development.
- To highlight the impact of recent pandemics on vaccine production.
- To emphasize the foundational role of adaptive immune responses in early-stage vaccine research.
Summary:
- Vaccine creation is typically a protracted process.
- The COVID-19 pandemic underscored and exacerbated existing development and production timelines.
- Preclinical and early clinical phases (1 and 2) of vaccine development are critically dependent on analyzing specific adaptive immune responses.
Impact:
- Understanding these immune responses is crucial for accelerating future vaccine development.
- This knowledge can help mitigate delays during public health crises.
- It provides a foundation for designing more effective and rapidly deployable vaccines.
More Related Videos
Related Concept Videos
Vaccinations
45.5K
Overview
45.5K
Development of Immunocompetence
477
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
477
Cancer Vaccines
539
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
539

